Division of Biomedical Ethics, Institute of Experimental Medicine, Christian-Albrechts-Universität zu Kiel, Arnold-Heller-Str. 3, Haus 28, 24105 Kiel, Germany.
Division of Biomedical Ethics, Institute of Experimental Medicine, Christian-Albrechts-Universität zu Kiel, Arnold-Heller-Str. 3, Haus 28, 24105 Kiel, Germany.
Int J Antimicrob Agents. 2015 Oct;46(4):359-61. doi: 10.1016/j.ijantimicag.2015.06.010. Epub 2015 Jul 20.
In this paper, we argue that antibiotic resistance (ABR) raises a number of ethical problems that have not yet been sufficiently addressed. We outline four areas in which ethical issues that arise in relation to ABR are particularly pressing. First, the emergence of multidrug-resistant and extensively drug-resistant infections exacerbates traditional ethical challenges of infectious disease control, such as the restriction of individual liberty for the protection of the public's health. Second, ABR raises issues of global distributive justice, both with regard to the overuse and lack of access to antibiotics. Third, the use of antibiotics in veterinary medicine raises serious concerns for animal welfare and sustainable farming practices. Finally, the diminishing effectiveness of antibiotics leads to questions about intergenerational justice and our responsibility for the wellbeing of future generations. We suggest that current policy discussions should take ethical conflicts into account and engage openly with the challenges that we outline in this paper.
在本文中,我们认为抗生素耐药性(ABR)引发了许多尚未得到充分解决的伦理问题。我们概述了与 ABR 相关的四个特别紧迫的伦理问题领域。首先,多药耐药和广泛耐药感染的出现加剧了传染病控制方面的传统伦理挑战,例如为保护公众健康而限制个人自由。其次,ABR 引发了全球分配正义问题,既涉及抗生素的过度使用,也涉及抗生素的获取不足。第三,在兽医实践中使用抗生素引起了人们对动物福利和可持续农业实践的严重关注。最后,抗生素效力的下降引发了关于代际公正以及我们对后代福祉的责任的问题。我们认为,当前的政策讨论应该考虑到伦理冲突,并公开应对本文中我们所概述的挑战。